JAMUNARANI VEERARAGHAVAN to Remission Induction
This is a "connection" page, showing publications JAMUNARANI VEERARAGHAVAN has written about Remission Induction.
Connection Strength
0.132
-
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer. Ann Oncol. 2019 06 01; 30(6):927-933.
Score: 0.105
-
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis. Cancer Treat Rev. 2020 Mar; 84:101965.
Score: 0.027